Combined TACE with Targeted and Immunotherapy versus TACE Alone Improves DFS in HCC with MVI: A Multicenter Propensity Score Matching Study

Combined TACE with Targeted and Immunotherapy versus TACE Alone Improves DFS in HCC with MVI: A Multicenter Propensity Score Matching Study

Xiaokun Chen,1,2,* Xiangan Wu,1,2,* Wei Peng,3– 5 Liguo Liu,6 Xiao Liu,1 Xueshuai Wan,1 Haifeng Xu,1 Yongchang Zheng,1 Haitao Zhao,1 Yilei Mao,1 Xin Lu,1 Xinting Sang,1 Xiaoyan Chang,7 Kang Zhou,8 Jie Pan,8 Mei Guan,9 Dandan Hu,3– 5 Haidong Tan,6 Yaojun Zhang,3– 5 Shunda Du1 1Departm...

Full description

Saved in:
Bibliographic Details
Main Authors: Chen X, Wu X, Peng W, Liu L, Liu X, Wan X, Xu H, Zheng Y, Zhao H, Mao Y, Lu X, Sang X, Chang X, Zhou K, Pan J, Guan M, Hu D, Tan H, Zhang Y, Du S
Format: Article
Language:English
Published: Dove Medical Press 2025-03-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
hepatocellular carcinoma
microvascular invasion
postoperative adjuvant therapy
targeted therapy
immunotherapy
transcatheter arterial chemoembolization
Online Access:https://www.dovepress.com/combined-tace-with-targeted-and-immunotherapy-versus-tace-alone-improv-peer-reviewed-fulltext-article-JHC
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items